Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -15.69% vs 7.73% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 27.52% vs -16.23% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "231.60",
          "val2": "274.70",
          "chgp": "-15.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "35.90",
          "val2": "41.50",
          "chgp": "-13.49%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.70",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "32.90",
          "val2": "25.80",
          "chgp": "27.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "155.10%",
          "val2": "150.90%",
          "chgp": "0.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -14.96% vs -3.66% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 30.54% vs -40.29% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "877.90",
          "val2": "1,032.30",
          "chgp": "-14.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.40",
          "val2": "132.90",
          "chgp": "-0.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.90",
          "val2": "3.50",
          "chgp": "-17.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.00",
          "val2": "-0.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "65.40",
          "val2": "50.10",
          "chgp": "30.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.00%",
          "val2": "91.20%",
          "chgp": "0.88%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

231.60

274.70

-15.69%

Operating Profit (PBDIT) excl Other Income

35.90

41.50

-13.49%

Interest

0.70

0.70

Exceptional Items

0.00

0.00

Consolidate Net Profit

32.90

25.80

27.52%

Operating Profit Margin (Excl OI)

155.10%

150.90%

0.42%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -15.69% vs 7.73% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 27.52% vs -16.23% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

877.90

1,032.30

-14.96%

Operating Profit (PBDIT) excl Other Income

132.40

132.90

-0.38%

Interest

2.90

3.50

-17.14%

Exceptional Items

-0.00

-0.20

100.00%

Consolidate Net Profit

65.40

50.10

30.54%

Operating Profit Margin (Excl OI)

100.00%

91.20%

0.88%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -14.96% vs -3.66% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 30.54% vs -40.29% in Dec 2024

All Annual Results